Malignant thyroid teratoma: an integrated analysis of case series/case reports

被引:3
作者
Huy Gia Vuong [1 ]
Nguyen, Truong P. X. [2 ]
Ngo, Hanh T. T. [3 ]
Hassell, Lewis [1 ]
Kakudo, Kennichi [4 ,5 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
[2] Cho Ray Hosp, Dept Pathol, Ho Chi Minh City, Vietnam
[3] Univ Med & Pharm, Dept Pathol, Ho Chi Minh City, Vietnam
[4] Izumi City Gen Hosp, Dept Pathol, Wake Cho, Izumi, Japan
[5] Izumi City Gen Hosp, Thyroid Dis Ctr, Wake Cho, Izumi, Japan
关键词
thyroid; malignant teratoma; overall survival; recurrence; metastasis; CERVICAL TERATOMAS; GLAND; TUMOR; ADULT;
D O I
10.1530/ERC-21-0142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant thyroid teratoma (MTT) is a very rare thyroid malignancy. These neoplasms have been reported only in case reports and small-sized case series so far. In this study, we searched for MTTs in the Surveillance, Epidemiology, and End Result (SEER) program during 1975-2016. Subsequently, we incorporated the SEER data with published MTT cases in the literature to analyze the characteristics and prognostic factors of MTTs. Integrated data were analyzed using chi-square or Fisher's exact test for categorical covariates, and t-test or Mann-Whitney test for continuous variables. We included 28 studies with 36 MTT cases and found additional 8 cases from the SEER program for final analyses. Our results showed that MTT is typically seen in adult females. These neoplasms were associated with an aggressive clinical course with high rates of extrathyroidal extension (80%) and nodal involvement (62%). During follow-up, the development of recurrence and metastases were common (42% and 46%, respectively), and one-third of patients died at the last follow-up. Large tumor size (P = 0.022) and the presence of metastases during follow-up (P = 0.008) were associated with a higher mortality rate. In conclusion, our study demonstrated the characteristic features of MTT patients and outlined some parameters associated with a negative outcome which could help clinicians better predict the clinical course of these neoplasms.
引用
收藏
页码:495 / 503
页数:9
相关论文
共 48 条
[41]  
Thompson LDR, 2000, CANCER, V88, P1149, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1149::AID-CNCR27>3.0.CO
[42]  
2-V
[43]   Primary Malignant Thyroid Teratoma: An Institutional Experience [J].
Ting, Jose ;
Bell, Diana ;
Ahmed, Salmaan ;
Ying, Anita ;
Waguespack, Steven G. ;
Tu, Shi-Ming ;
Weber, Randal ;
Zafereo, Mark .
THYROID, 2019, 29 (02) :229-236
[44]   Malignant teratoma of the thyroid: Aggressive chemoradiation therapy is required after surgery [J].
Tsang, RW ;
Brierley, JD ;
Asa, SL ;
Sturgeon, JF .
THYROID, 2003, 13 (04) :401-404
[45]  
Ueno NT, 1998, HEAD NECK-J SCI SPEC, V20, P649, DOI 10.1002/(SICI)1097-0347(199810)20:7<649::AID-HED13>3.3.CO
[46]  
2-X
[47]   Malignant Thyroid Teratoma: Report of an Aggressive Tumor in a 64-Year-Old Man [J].
Vilallonga, R. ;
Zafon, C. ;
Ruiz-Marcellan, C. ;
Obiols, G. ;
Fort, J. M. ;
Baena, J. A. ;
Villanueva, B. ;
Garcia, A. ;
Sobrinho-Simoes, M. .
ENDOCRINE PATHOLOGY, 2013, 24 (03) :132-135
[48]   Role of radiotherapy in treating patients with primary malignant mediastinal non-seminomatous germ cell tumor: A 21-year experience at a single institution [J].
Wang, Jianyang ;
Bi, Nan ;
Wang, Xiaozhen ;
Hui, Zhouguang ;
Liang, Jun ;
Lv, Jima ;
Zhou, Zongmei ;
Feng, Qin Fu ;
Xiao, Zefen ;
Chen, Dongfu ;
Zhang, Hongxing ;
Yin, Weibo ;
Wang, Luhua .
THORACIC CANCER, 2015, 6 (04) :399-406